Although the putative C1P receptor(s) is (are) still to be fully characterized and cloned, these, together with CERK, may be highly relevant to promote the development of a new generation of cancer metabolism-targeting agents to aid in the prevention or cure of cancer. The gene discussed is CERK; the disease is cancer.